The Clorox Company (NYSE:CLX) Holdings Boosted by WCM Investment Management LLC

WCM Investment Management LLC grew its holdings in The Clorox Company (NYSE:CLX) by 356.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,466 shares of the company’s stock after purchasing an additional 5,829 shares during the period. WCM Investment Management LLC’s holdings in Clorox were worth $1,220,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Los Angeles Capital Management LLC raised its position in Clorox by 5.6% during the third quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock valued at $31,266,000 after buying an additional 10,149 shares during the period. Jensen Investment Management Inc. increased its holdings in shares of Clorox by 106.1% in the 3rd quarter. Jensen Investment Management Inc. now owns 58,155 shares of the company’s stock valued at $9,474,000 after purchasing an additional 29,940 shares during the period. Houlihan Financial Resource Group Ltd. purchased a new stake in shares of Clorox in the third quarter worth approximately $201,000. Kerusso Capital Management LLC grew its position in Clorox by 6.4% during the third quarter. Kerusso Capital Management LLC now owns 19,011 shares of the company’s stock valued at $3,097,000 after purchasing an additional 1,148 shares in the last quarter. Finally, Lindbrook Capital LLC increased its stake in Clorox by 9.9% in the 3rd quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock valued at $159,000 after buying an additional 88 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Buying and Selling at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.57% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the stock. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and lifted their target price for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Evercore ISI lowered their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. DA Davidson raised their price target on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Citigroup boosted their price target on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Finally, Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and raised their price objective for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Five analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, Clorox presently has an average rating of “Hold” and a consensus price target of $155.00.

Clorox Stock Down 0.2 %

CLX stock opened at $164.78 on Wednesday. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The company has a 50-day moving average of $162.28 and a two-hundred day moving average of $146.95. The stock has a market capitalization of $20.40 billion, a price-to-earnings ratio of 57.41, a price-to-earnings-growth ratio of 3.05 and a beta of 0.41. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $169.09.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.49 EPS. As a group, equities research analysts anticipate that The Clorox Company will post 6.85 EPS for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd were given a $1.22 dividend. The ex-dividend date was Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 2.96%. Clorox’s dividend payout ratio (DPR) is currently 170.04%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.